Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 193

    1.

    Impact of incident diabetes and incident nonfatal cardiovascular disease on 18-year mortality: the multiple risk factor intervention trial experience.

    Eberly LE, Cohen JD, Prineas R, Yang L; Intervention Trial Research group.

    Diabetes Care. 2003 Mar;26(3):848-54.PMID: 12610048 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Modification Trial.

    Howard BV, Van Horn L, Hsia J, Manson JE, Stefanick ML, Wassertheil-Smoller S, Kuller LH, LaCroix AZ, Langer RD, Lasser NL, Lewis CE, Limacher MC, Margolis KL, Mysiw WJ, Ockene JK, Parker LM, Perri MG, Phillips L, Prentice RL, Robbins J, Rossouw JE, Sarto GE, Schatz IJ, Snetselaar LG, Stevens VJ, Tinker LF, Trevisan M, Vitolins MZ, Anderson GL, Assaf AR, Bassford T, Beresford SA, Black HR, Brunner RL, Brzyski RG, Caan B, Chlebowski RT, Gass M, Granek I, Greenland P, Hays J, Heber D, Heiss G, Hendrix SL, Hubbell FA, Johnson KC, Kotchen JM.

    JAMA. 2006 Feb 8;295(6):655-66.PMID: 16467234 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Relationship of baseline serum cholesterol levels in 3 large cohorts of younger men to long-term coronary, cardiovascular, and all-cause mortality and to longevity.

    Stamler J, Daviglus ML, Garside DB, Dyer AR, Greenland P, Neaton JD.

    JAMA. 2000 Jul 19;284(3):311-8.PMID: 10891962 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Maximal exercise electrocardiography responses and coronary heart disease mortality among men with diabetes mellitus.

    Lyerly GW, Sui X, Church TS, Lavie CJ, Hand GA, Blair SN.

    Circulation. 2008 May 27;117(21):2734-42. Epub 2008 May 19.PMID: 18490521 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Impact of diabetes and previous myocardial infarction on long-term survival: 25-year mortality follow-up of primary screenees of the Multiple Risk Factor Intervention Trial.

    Vaccaro O, Eberly LE, Neaton JD, Yang L, Riccardi G, Stamler J; Multiple Risk Factor Intervention Trial Research Group.

    Arch Intern Med. 2004 Jul 12;164(13):1438-43.PMID: 15249353 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults.

    Malik S, Wong ND, Franklin SS, Kamath TV, L'Italien GJ, Pio JR, Williams GR.

    Circulation. 2004 Sep 7;110(10):1245-50. Epub 2004 Aug 23.PMID: 15326067 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and noncardiovascular diseases?

    DECODE Study Group, European Diabetes Epidemiology Group.

    Diabetes Care. 2003 Mar;26(3):688-96.PMID: 12610023 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Depressive symptoms and mortality in men: results from the Multiple Risk Factor Intervention Trial.

    Gump BB, Matthews KA, Eberly LE, Chang YF; MRFIT Research Group.

    Stroke. 2005 Jan;36(1):98-102. Epub 2004 Nov 29.PMID: 15569872 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Favorable cardiovascular risk profile in young women and long-term risk of cardiovascular and all-cause mortality.

    Daviglus ML, Stamler J, Pirzada A, Yan LL, Garside DB, Liu K, Wang R, Dyer AR, Lloyd-Jones DM, Greenland P.

    JAMA. 2004 Oct 6;292(13):1588-92.PMID: 15467061 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Multiple-stage screening and mortality in the Multiple Risk Factor Intervention Trial.

    Eberly LE, Neaton JD, Thomas AJ, Yu D; Multiple Risk Factor Intervention Trial Research Group.

    Clin Trials. 2004;1(2):148-61.PMID: 16281887 [PubMed - indexed for MEDLINE]Related articles

    11.

    The significant effect of diabetes duration on coronary heart disease mortality: the Framingham Heart Study.

    Fox CS, Sullivan L, D'Agostino RB Sr, Wilson PW; Framingham Heart Study.

    Diabetes Care. 2004 Mar;27(3):704-8.PMID: 14988289 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men.

    Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, Salonen JT.

    JAMA. 2002 Dec 4;288(21):2709-16.PMID: 12460094 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Metabolic syndrome: risk factor distribution and 18-year mortality in the multiple risk factor intervention trial.

    Eberly LE, Prineas R, Cohen JD, Vazquez G, Zhi X, Neaton JD, Kuller LH; Multiple Risk Factor Intervention Trial Research Group.

    Diabetes Care. 2006 Jan;29(1):123-30.PMID: 16373907 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Relationship of elevated casual blood glucose level with coronary heart disease, cardiovascular disease and all-cause mortality in a representative sample of the Japanese population. NIPPON DATA80.

    Kadowaki S, Okamura T, Hozawa A, Kadowaki T, Kadota A, Murakami Y, Nakamura K, Saitoh S, Nakamura Y, Hayakawa T, Kita Y, Okayama A, Ueshima H; NIPPON DATA Research Group.

    Diabetologia. 2008 Apr;51(4):575-82. Epub 2008 Jan 16.PMID: 18197396 [PubMed - indexed for MEDLINE]Related articles

    16.

    Diabetes mellitus: subclinical cardiovascular disease and risk of incident cardiovascular disease and all-cause mortality.

    Kuller LH, Velentgas P, Barzilay J, Beauchamp NJ, O'Leary DH, Savage PJ.

    Arterioscler Thromb Vasc Biol. 2000 Mar;20(3):823-9.PMID: 10712409 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Alanine aminotransferase predicts coronary heart disease events: a 10-year follow-up of the Hoorn Study.

    Schindhelm RK, Dekker JM, Nijpels G, Bouter LM, Stehouwer CD, Heine RJ, Diamant M.

    Atherosclerosis. 2007 Apr;191(2):391-6. Epub 2006 May 8.PMID: 16682043 [PubMed - indexed for MEDLINE]Related articles

    18.

    Glucose intolerance and 23-year risk of coronary heart disease and total mortality: the Honolulu Heart Program.

    Rodriguez BL, Lau N, Burchfiel CM, Abbott RD, Sharp DS, Yano K, Curb JD.

    Diabetes Care. 1999 Aug;22(8):1262-5.PMID: 10480768 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Impact of metabolic syndrome criteria on cardiovascular disease risk in people with newly diagnosed type 2 diabetes.

    Guzder RN, Gatling W, Mullee MA, Byrne CD.

    Diabetologia. 2006 Jan;49(1):49-55. Epub 2005 Dec 10.PMID: 16341841 [PubMed - indexed for MEDLINE]Related articles

    20.

    Impact of minor electrocardiographic ST-segment and/or T-wave abnormalities on cardiovascular mortality during long-term follow-up.

    Greenland P, Xie X, Liu K, Colangelo L, Liao Y, Daviglus ML, Agulnek AN, Stamler J.

    Am J Cardiol. 2003 May 1;91(9):1068-74.PMID: 12714148 [PubMed - indexed for MEDLINE]Related articles